Timothy Edwin Kelly
Chief Financial Officer · Praxis Precision Medicines, Inc.
Individual
- 2024
- May 20, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Timothy Edwin Kelly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adage Capital Management, L.P. - $33.20M in PRAX purchases and sales in the last 12 months
- Alex Nemiroff - $4.85M in PRAX purchases and sales in the last 12 months
- Jill Desimone - $3.61M in PRAX purchases and sales in the last 12 months
- Lauren Mastrocola - $2.61M in PRAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Timothy Edwin Kelly?
Timothy Edwin Kelly is a corporate insider, tracked as Chief Financial Officer of Praxis Precision Medicines, Inc. (PRAX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Timothy Edwin Kelly last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 3 filings going back to 2024.
